GRAHAM RICHARD A 4
4 · Theravance Biopharma, Inc. · Filed Nov 1, 2023
Insider Transaction Report
Form 4
GRAHAM RICHARD A
SVP, Development
Transactions
- Award
Ordinary Shares
2023-10-30+15,000→ 349,321 total
Footnotes (1)
- [F1]On March 1, 2023 the reporting person was granted a performance restricted stock unit award that vests based on the achievement of a performance condition by December 31, 2023 and continued employment. On October 30, 2023 the performance conditions were achieved. As a result 50% of the restricted stock units will vest on November 20, 2023 and the remaining 50% of the restricted stock units will vest on November 20, 2024, subject to the reporting person's continued service.